Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101293832A details a DCC-catalyzed synthesis of chlorogenic acid. Offers mild conditions, simplified purification, and scalable production for pharmaceutical applications.
Novel dual-acid catalyzed route for high-purity alpha-terpineol. Reduces cost and improves selectivity compared to traditional turpentine hydration methods.
Patent CN103980134A reveals high-purity S-metoprolol synthesis. Enhanced ee value and scalable process offer significant supply chain stability.
Patent CN111233707B reveals a high-yield synthesis of 4-fluorobenzoylacetonitrile using triflic acid, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN120965548A reveals a cost-effective synthesis route for high-purity pyrrole derivatives used in flavors and cosmetics with scalable industrial potential.
Novel deuterium exchange synthesis for L-Aspartic acid 3 3 D2 ensures high purity and cost efficiency for stable isotope labeling applications in pharmaceutical research and development.
Patent CN111763222B reveals a green route for edoxaban free base. Eliminate Pd catalysts and genotoxic impurities for cost-effective API manufacturing.
Patent CN107935842A details a novel Grignard route for high-purity benzoic acid derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN107513047B reveals a microwave-assisted green process for ceftazidime intermediates, offering high purity, reduced costs, and scalable manufacturing solutions.
Patent CN107513047B details a green microwave-assisted process for ceftazidime intermediates, offering >99% purity and significant cost reduction via triethyl phosphite substitution.
Patent CN108911972B details a novel racemization recovery method for sitafloxacin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN104370755A reveals efficient synthesis for Dolutegravir intermediates. Enables cost reduction and scalable supply chain for global pharmaceutical manufacturers.
Novel Pd-catalyzed method for gamma-arylation. High yield, regioselective. Cost-effective supply chain solution for pharmaceutical manufacturing.
Patent CN102643236A details a green synthesis of chiral imidazolium ionic liquids from natural amino acids, offering high purity and cost-effective manufacturing solutions.
Advanced synthesis of 3,3-dimethylcyclopropane-1,2-dicarboxylic anhydride via safe oxidation. Reliable supplier for Hepatitis C drug intermediates with optimized cost and yield.
Patent CN103172645B details a robust artemisinin synthesis route offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global buyers.
Patent CN103193791B reveals a scalable chemical synthesis for Artemisinin, offering cost reduction and supply stability for pharmaceutical manufacturing.
Patent CN101903366B details a novel ruthenium-catalyzed hydrogenation and isomerization process for producing high-purity cis-rose oxide, offering significant cost and supply chain advantages.
Novel cyclization process for thienopyrrole derivatives avoiding explosive hazards. Enhanced safety and scalability for glycogen phosphorylase inhibitor production.
Patent CN101801914B details a streamlined route from shikimic acid to 4,5-diamino derivatives, offering improved yield and purity for antiviral API manufacturing.